Valcon Medical A/S
Public limited companyCVR 40086714LyngeActive
Valcon Medical A/S is a public limited company, based in Lynge, active in manufacture of other organic basic chemicals, founded in 2018. The company made a loss in both 2024 and 2025, most recently DKK 11.2m. Equity grew to DKK 11.4m in 2025.
Key figures · financial year 2025
Gross profitDKK 2.1m+107.6% vs. 2024
Net profit−DKK 11.2m+73.2% vs. 2024
EquityDKK 11.4m+843.2% vs. 2024
Employees14latest month from CVR
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss got smaller: from DKK 41.7m to DKK 11.2m (2024 → 2025).
- Equity rose 843% (2024 → 2025), to DKK 11.4m.
Employees
- 2 more employees than a year earlier: 14 (07/2026) against 12 (07/2025).
Management and owners, last 24 months
- New in management: Peter Emil Guldmann Sigetty (ceo, 20/05/2025), William Muecke (board member, 25/08/2025) and Ruchir Ashok Kadakia (board member, 25/08/2025) (+5).
- Stepped down: Peter Emil Guldmann Sigetty (director, 19/05/2025), Nelson Camargo Cury (board member, 25/08/2025) and Mike Steen Hansen (board member, 25/08/2025) (+7).
- New owners registered: Bts DK ApS (25/08/2025), 1187243 B.C.Ltd. (25/08/2025) and Artemis Founders Investments, LLC (25/08/2025).
- No longer registered as owner: Cannabis Science Invest ApS (25/08/2025), Artemis Founders Investments, LLC (24/08/2025) and Greenfield Global Opportunities Fund Limited Partnership (25/08/2025) (+4).
Registrations, last 24 months
- 27/08/2026: Share capital changed from 15,559,638 DKK to 27,193,436 DKK
- 14/01/2026: Merger registered in CVR
- 30/12/2025: Share capital changed from 12,286,707 DKK to 15,559,638 DKK
- 25/08/2025: Share capital changed from 2,898,675 DKK to 12,286,707 DKK
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | −1,133 | −6,235 | −15,350 | −15,119 | −28,232 | 2,140 | +107.6% |
| Operating profit (EBIT) | −3,828 | −12,887 | – | – | – | −11,435 | – |
| Profit before tax | −4,515 | −14,322 | – | – | −39,987 | −13,447 | +66.4% |
| Net profit | −3,518 | −10,627 | −17,079 | −30,262 | −41,728 | −11,199 | +73.2% |
| Total assets | 32,540 | 57,153 | 67,255 | 50,294 | 26,909 | 28,171 | +4.7% |
| Equity | 640 | 49,435 | 56,675 | 38,684 | 1,211 | 11,421 | +843.2% |
| Liabilities | 31,900 | 7,717 | 10,579 | 11,610 | 25,698 | 16,750 | −34.8% |
| Cash and cash equivalents | 4,406 | 11,994 | 6,627 | 1,310 | 29 | 1,199 | +4,004.2% |
| Average number of employees | 8 | 12 | 20 | 19 | 14 | 12 | −14.3% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLoss for 6 years in a row
Net result has been negative in 2020–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 11/05/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 30/06/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 30/06/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 03/07/2023 | The company | PDFXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 24/06/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 29/06/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
9 companies in the databaseComparison with the other companies in manufacture of other organic basic chemicals based on the latest financial year.
Gross profitDKK 2.1mNo. 7 of 9
Better than 25% of the companies in the industry
EquityDKK 11.4mNo. 4 of 9
Better than 63% of the companies in the industry
Number of employees14No. 5 of 9
Better than 50% of the companies in the industry
Industry median: gross profit DKK 7.9m, net profit DKK 1.2m, equity DKK 7.3m, 12 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 29,521of 69,742 Better than 58% | No. 8,306of 69,964 Better than 88% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 16,253of 33,588 Better than 52% | No. 3,413of 33,687 Better than 90% |
| All companies of type A/S18,025 companies in the comparison | No. 14,522of 17,786 Better than 18% | No. 8,205of 18,024 Better than 54% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Manufacture of other organic basic chemicalsGross profit
- Valcon Medical A/SDKK 2.1m
- Novozymes A/SDKK 2.2bn
- Syntese A/SDKK 159m
Net profit
- Valcon Medical A/S−DKK 11.2m
- Novozymes A/SDKK 583.6m
- Syntese A/SDKK 8.7m
Equity
- Valcon Medical A/SDKK 11.4m
- Novozymes A/SDKK 10.9bn
- Syntese A/SDKK 84.6m
Employees
- Valcon Medical A/S14
- Novozymes A/S3,508
- Syntese A/S156
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership RegisterOwners
- Bts DK ApS66.67%
Valcon Medical A/S
Management
5 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Peter Emil Guldmann Sigetty | CEO | 20/05/2025 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| William Muecke | Board member | 25/08/2025 |
| Ruchir Ashok Kadakia | Board member | 25/08/2025 |
| Alex Sung Kwon | Chair of the board | 25/08/2025 |
| Douglas Fischer | Board member | 07/05/2026 |
- Auditor
- Crowe Statsautoriseret Revisionsinteressentskab
- Founders
- Medican A/S, PESI Holding ApS, Cannabis Science Invest ApS, 1187243 B.C.Ltd.
Former management (16)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Mike Steen Hansen | Chair of the board | 13/12/2018 | 17/12/2019 |
| Farzad Jahanshahi | Board member | 13/12/2018 | 11/12/2020 |
| Peter Emil Guldmann Sigetty | Director | 13/12/2018 | 19/05/2025 |
| Peter Emil Guldmann Sigetty | Board member | 13/12/2018 | 28/02/2019 |
| Pete Patterson | Board member | 13/12/2018 | 19/08/2019 |
| Nelson Camargo Cury | Board member | 19/08/2019 | 25/08/2025 |
| Joel David Sherlock | Board member | 19/08/2019 | 17/12/2019 |
| Mike Steen Hansen | Board member | 18/12/2019 | 25/08/2025 |
| Joel David Sherlock | Chair of the board | 18/12/2019 | 19/05/2025 |
| William Muecke | Board member | 30/04/2020 | 19/05/2025 |
| Pete Patterson | CEO | 21/01/2021 | 20/05/2025 |
| Diego Francisco Gomez Dueñas | Board member | 02/06/2021 | 27/06/2023 |
| E Stanton Mclean | Board member | 29/06/2023 | 25/08/2025 |
| Joel David Sherlock | Board member | 20/05/2025 | 07/05/2026 |
| William Muecke | Chair of the board | 20/05/2025 | 24/08/2025 |
| Pete Patterson | Board member | 25/08/2025 | 07/05/2026 |
Signing rule: Selskabet tegnes af 1 direktør sammen med bestyrelsesformanden eller af 3 bestyrelsesmedlemmer i forening.
Address and production units
1 active production unitsIndustrivej 12
3540 Lynge
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Valcon Medical A/S | Industrivej 12, 3540 Lynge | 15 | 1024207524 |
Purpose
Selskabets formål er at forestå kontraktbaseret forarbejdning og produktion af private label produkter relateret til botanisk biomasse og industriel hamp med henblik på udvinding højkvalitets ekstrakter og olier samt dermed beslægtet virksomhed.
The purpose is quoted from the register in Danish.
Changes year by year
98 registered events102018
162019
42020
92021
62022
92023
102024
262025
82026
20268 changescapital 1 · ownership 2 · accounts 1 · management 3 · merger 1
- CapitalShare capital changed from 15,559,638 DKK to 27,193,436 DKK
- OwnershipArtemis Founders Investments, LLC is no longer registered as owner
- Ownership1187243 B.C.Ltd. is no longer registered as owner
- AccountsAnnual report for 2025 published
- ManagementDouglas Fischer appointed board member
- ManagementPete Patterson stepped down as board member
- ManagementJoel David Sherlock stepped down as board member
- MergerMerger registered in CVR
202526 changescapital 2 · management 15 · ownership 8 · accounts 1
- CapitalShare capital changed from 12,286,707 DKK to 15,559,638 DKK
- CapitalShare capital changed from 2,898,675 DKK to 12,286,707 DKK
- ManagementPete Patterson appointed board member
- ManagementAlex Sung Kwon appointed chair of the board
- ManagementRuchir Ashok Kadakia appointed board member
- ManagementWilliam Muecke appointed board member
- ManagementE Stanton Mclean stepped down as board member
- ManagementMike Steen Hansen stepped down as board member
- ManagementNELSON CAMARGO CURY stepped down as board member
- OwnershipBTS DK ApS registered as owner (66.67%)
- OwnershipArtemis Founders Investments, LLC registered as owner (5%)
- Ownership1187243 B.C.Ltd. registered as owner (5%)
- OwnershipArtemis Accelerator Fund LLC is no longer registered as owner
- OwnershipGREENFIELD GLOBAL OPPORTUNITIES FUND LIMITED PARTNERSHIP is no longer registered as owner
- OwnershipCannabis Science Invest ApS is no longer registered as owner
- ManagementWilliam Muecke stepped down as chair of the board
- Ownership1187243 B.C.Ltd. is no longer registered as owner
- OwnershipArtemis Founders Investments, LLC is no longer registered as owner
- AccountsAnnual report for 2024 published
- ManagementWilliam Muecke appointed chair of the board
- ManagementPeter Emil Guldmann Sigetty appointed ceo
- ManagementJoel David Sherlock appointed board member
- ManagementPete Patterson stepped down as ceo
- ManagementWilliam Muecke stepped down as board member
- ManagementJoel David Sherlock stepped down as chair of the board
- ManagementPeter Emil Guldmann Sigetty stepped down as director
202410 changesaccounts 1 · capital 4 · ownership 5
- AccountsAnnual report for 2023 published
- CapitalShare capital changed from 2,858,269 DKK to 2,898,675 DKK
- Ownership1187243 B.C.Ltd. registered as owner (5%)
- Ownership1187243 B.C.Ltd. is no longer registered as owner
- CapitalShare capital changed from 2,758,174 DKK to 2,858,269 DKK
- Ownership1187243 B.C.Ltd. registered as owner (10%)
- OwnershipArtemis Accelerator Fund LLC registered as owner (15%)
- Ownership1187243 B.C.Ltd. is no longer registered as owner
- CapitalShare capital changed from 2,684,161 DKK to 2,758,174 DKK
- CapitalShare capital changed from 2,669,423 DKK to 2,684,161 DKK
20239 changescapital 1 · ownership 4 · accounts 1 · management 2 · industry 1
- CapitalShare capital changed from 2,008,323 DKK to 2,669,423 DKK
- OwnershipGREENFIELD GLOBAL OPPORTUNITIES FUND LIMITED PARTNERSHIP registered as owner (10%)
- Ownership1187243 B.C.Ltd. registered as owner (15%)
- OwnershipGREENFIELD GLOBAL OPPORTUNITIES FUND LIMITED PARTNERSHIP is no longer registered as owner
- Ownership1187243 B.C.Ltd. is no longer registered as owner
- AccountsAnnual report for 2022 published
- ManagementE Stanton Mclean appointed board member
- ManagementDiego Francisco Gomez Dueñas stepped down as board member
- IndustryIndustry changed to Manufacture of other organic basic chemicals (201400)
20226 changescapital 3 · ownership 2 · accounts 1
- CapitalShare capital changed from 1,968,823 DKK to 2,008,323 DKK
- OwnershipPESI Holding ApS is no longer registered as owner
- OwnershipValcon Medical A/S is no longer registered as owner
- AccountsAnnual report for 2021 published
- CapitalShare capital changed from 1,914,588 DKK to 1,968,823 DKK
- CapitalShare capital changed from 1,830,777 DKK to 1,914,588 DKK
20219 changescapital 2 · ownership 3 · accounts 1 · name 1 · management 2
- CapitalShare capital changed from 1,780,777 DKK to 1,830,777 DKK
- OwnershipPESI Holding ApS registered as owner (5%)
- AccountsAnnual report for 2020 published
- NameName changed from Aureum A/S to Valcon Medical A/S
- CapitalShare capital changed from 608,047 DKK to 1,780,777 DKK
- ManagementDiego Francisco Gomez Dueñas appointed board member
- OwnershipArtemis Founders Investments, LLC registered as owner (25%)
- OwnershipPESI Holding ApS is no longer registered as owner
- ManagementPete Patterson appointed ceo
20204 changesmanagement 2 · ownership 2
- ManagementFarzad Jahanshahi stepped down as board member
- OwnershipValcon Medical A/S registered as owner (5%)
- OwnershipMedican A/S is no longer registered as owner
- ManagementWilliam Muecke appointed board member
201916 changesmanagement 8 · capital 2 · ownership 5 · address 1
- ManagementJoel David Sherlock appointed chair of the board
- ManagementMike Steen Hansen appointed board member
- ManagementJoel David Sherlock stepped down as board member
- ManagementMike Steen Hansen stepped down as chair of the board
- ManagementNELSON CAMARGO CURY appointed board member
- ManagementJoel David Sherlock appointed board member
- ManagementPete Patterson stepped down as board member
- CapitalShare capital changed from 537,500 DKK to 608,047 DKK
- OwnershipGREENFIELD GLOBAL OPPORTUNITIES FUND LIMITED PARTNERSHIP registered as owner (15%)
- CapitalShare capital changed from 500,000 DKK to 537,500 DKK
- OwnershipMedican A/S registered as owner (20%)
- OwnershipCannabis Science Invest ApS registered as owner (5%)
- OwnershipCannabis Science Invest ApS is no longer registered as owner
- OwnershipMedican A/S is no longer registered as owner
- AddressMoved to Industrivej 12, 3540 Lynge
- ManagementPeter Emil Guldmann Sigetty stepped down as board member
201810 changesfounded 1 · management 5 · ownership 4
- FoundedRegistered as Aureum A/S
- ManagementFarzad Jahanshahi appointed board member
- ManagementPete Patterson appointed board member
- ManagementPeter Emil Guldmann Sigetty appointed board member
- ManagementPeter Emil Guldmann Sigetty appointed director
- ManagementMike Steen Hansen appointed chair of the board
- OwnershipPESI Holding ApS registered as owner (5%)
- Ownership1187243 B.C.Ltd. registered as owner (10%)
- OwnershipCannabis Science Invest ApS registered as owner (25%)
- OwnershipMedican A/S registered as owner (25%)
Related companies
Same people in management
- Powercare A/Svia Mike Steen Hansen
- Aqua D'or Mineral Water A/Svia Mike Steen Hansen
- Apj El Anlæg A/Svia Mike Steen Hansen
- HOS Hjem ApSvia Mike Steen Hansen
- Valeos Pharma A/Svia Farzad Jahanshahi
- Dige VVS A/Svia Mike Steen Hansen
Largest in the industry
- Novozymes A/SDKK 2.2bn
- Syntese A/SDKK 159m
- Vertanical Denmark ApSDKK 33.7m
- Kemi-Tech ApSDKK 26.6m
- Burnblock ApSDKK 7.9m
- Grolman Nordic Specialty Chemicals ApSDKK 5.8m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.